b
lymphocyt
b
cell
play
critic
role
adapt
immun
provid
protect
pathogen
product
specif
antibodi
b
cell
recogn
respond
pathogenderiv
antigen
surfac
b
cell
receptor
bcr
bcr
two
interrel
function
b
cell
activ
first
initi
signal
cascad
result
transcript
varieti
gene
associ
b
cell
activ
pierc
liu
second
mediat
antigen
uptak
process
lead
antigen
present
cell
within
mhc
class
ii
context
full
activ
b
cell
lanzavecchia
similarli
bcrmediat
antigen
intern
shown
facilit
present
lipid
antigen
context
result
recruit
inkt
cell
help
barral
et
al
leadbett
et
al
transport
tlr
agonist
result
signal
marshakrothstein
hou
et
al
tlr
recogn
structur
conserv
sequenc
pathogenassoci
ligand
provid
costimul
immun
cell
involv
promot
b
cell
respons
also
autoimmun
leadbett
et
al
pasar
medzhitov
christensen
et
al
defranco
et
al
shlomchik
weisel
mice
long
known
even
absenc
bcr
signal
cell
help
naiv
b
cell
undergo
prolifer
differenti
respons
tlr
ligand
lp
cpg
coutinho
et
al
krieg
eckldorna
batista
human
b
cell
tlr
signal
suggest
repres
third
signal
requir
polyclon
activ
naiv
b
cell
ruprecht
lanzavecchia
furthermor
tlr
signal
also
implic
antibodi
respons
vivo
longterm
b
cell
memori
plasma
cell
differenti
bernasconi
et
al
similarli
stimul
b
cell
via
tlr
ligand
associ
promot
plasma
cell
differenti
rawl
et
al
howev
precis
signal
requir
antiha
antibodi
crossreact
multipl
subtyp
show
neutral
activ
although
antibodi
may
arisen
result
previou
influenza
infect
also
obtain
antibodi
nonhivinfect
donor
indic
gener
antibodi
without
prior
antigen
exposur
overal
novel
approach
use
rapidli
produc
therapeut
antibodi
potenti
assess
immunogen
candid
antigen
could
exploit
futur
vaccin
develop
promot
termin
b
cell
differenti
topic
intens
investig
nutt
et
al
recent
year
potent
immunostimulatori
properti
cpg
oligodeoxynucleotid
cpgodn
exploit
studi
human
antibodi
respons
report
cpg
dna
enhanc
effici
ebvimmort
b
cell
traggiai
et
al
yu
et
al
furthermor
use
ebvtransform
human
b
cell
fusion
increas
hybridoma
format
much
compar
untransform
pbmc
yu
et
al
strategi
led
gener
neutral
antibodi
influenza
strain
respons
pandem
yu
et
al
also
exploit
studi
antibodi
respons
mani
pathogen
includ
cmv
macagno
et
al
influenza
viru
yu
et
al
corti
et
al
hiv
buchach
et
al
dengu
viru
dejnirattisai
et
al
smith
et
al
solubl
oligonucleotid
contain
unmethyl
cpg
therefor
use
expand
human
b
cell
popul
vitro
infect
vaccin
individu
howev
strategi
labori
time
consum
extens
screen
need
retriev
compar
rare
antigenspecif
b
cell
contain
within
expand
b
cell
popul
last
decad
direct
clone
ig
variabl
gene
singl
cell
babcook
et
al
wardemann
et
al
recent
nextgener
sequenc
igh
variabl
gene
facilit
isol
antigenspecif
b
cell
plasmablast
memori
cell
popul
peripher
blood
approxim
week
infect
vaccin
wrammert
et
al
scheid
et
al
smith
et
al
zhu
et
al
one
limit
use
antigenspecif
b
cell
isol
method
impos
time
frame
humor
respons
infect
immun
typic
peak
postvaccin
return
bare
detect
level
specif
antibodi
day
wrammert
et
al
result
vivo
studi
underscor
need
fast
inexpens
vitro
system
recapitul
least
featur
human
immun
respons
antigenspecif
b
cell
activ
key
step
initi
immun
respons
vitro
activ
b
cell
antigendepend
manner
difficult
achiev
wide
haplotyp
variat
mhc
ii
necessit
use
uniqu
cell
specif
particular
mhc
ii
activ
b
cell
vitro
fauci
et
al
borrebaeck
et
al
overcom
limit
develop
novel
vitro
strategi
stimul
human
b
cell
streptavidin
nanoparticl
conjug
gpg
antigen
eckldorna
batista
b
cell
produc
antigenspecif
antibodi
identifi
quantifi
character
determin
antibodi
repertoir
valid
util
approach
use
human
b
cell
healthi
individu
wide
rang
infecti
target
includ
tetanu
toxoid
tt
hemagglutinin
ha
sever
subtyp
influenza
hiv
envelop
protein
also
determin
physiolog
effect
antibodi
measur
antigenbind
affin
neutral
abil
addit
demonstr
method
allow
select
vitro
recal
human
b
cell
overcom
difficulti
either
isol
infrequ
antigenspecif
memori
b
cell
present
peripher
blood
healthi
subject
normal
circumst
requir
vaccin
infect
use
plasmablast
sourc
antigenspecif
cell
novel
valuabl
approach
rapidli
gener
therapeut
antibodi
also
acceler
immunogen
design
test
earli
character
human
vaccin
obviat
need
labori
timeconsum
expens
clinic
trial
previou
studi
demonstr
vitro
stimul
human
b
cell
tlr
effici
way
induc
activ
prolifer
cell
irrespect
bcr
specif
bernasconi
et
al
pinna
et
al
find
exploit
effici
way
retriev
human
monoclon
antibodi
vitro
traggiai
et
al
hypothes
deliveri
tlr
ligand
via
bcrmediat
intern
might
repres
way
exclus
activ
b
cell
particular
bcr
specif
determin
best
stimulatori
condit
activ
first
took
advantag
antibodi
target
cpg
bcr
circul
human
b
cell
bear
bcr
chain
rest
bear
chain
coat
streptavidin
polystyren
nanoparticl
mixtur
biotinyl
antibodi
tlr
ligand
cpg
previous
describ
mice
eckldorna
batista
determin
whether
could
use
nanoparticl
vitro
select
activ
memori
b
cell
express
bcr
celltrac
violetlabel
human
memori
b
cell
obtain
healthi
donor
cultur
presenc
cytokin
cocktail
nanoparticl
coat
either
cpg
cpg
alon
solubl
cpg
stimul
control
stimul
flow
cytometri
use
measur
b
cell
prolifer
dilut
celltrac
violet
expect
solubl
cpg
induc
robust
prolifer
b
cell
irrespect
whether
express
vs
respect
fig
contrast
cpg
render
particul
trigger
prolifer
unless
also
present
particul
could
stimul
b
cell
lead
prolifer
fig
result
show
intern
via
bcr
particul
cpg
use
select
activ
memori
b
cell
bear
particular
bcr
vitro
investig
whether
type
stimul
could
also
lead
antibodi
secret
measur
total
igg
product
cultur
supernat
eli
sa
poststimul
stimul
particul
cpg
induc
detect
antibodi
cultur
supernat
contrast
detect
increas
igg
secret
b
cell
stimul
either
solubl
cpg
fig
b
left
expect
increas
igg
level
correspond
similar
increas
igg
antibodi
bear
chain
fig
b
middl
importantli
antibodi
could
detect
supernat
b
cell
stimul
indic
detect
result
specif
target
fig
b
right
therefor
result
indic
vitro
target
particul
cpg
via
bcr
trigger
select
antibodi
product
interestingli
note
although
solubl
cpg
stimul
induc
b
cell
prolifer
amount
secret
cultur
lower
produc
respons
wonder
whether
could
caus
b
cell
reach
differ
stage
plasma
cell
differenti
condit
investig
use
flow
cytometri
monitor
differenti
prolifer
cell
express
surfac
molecul
upregul
plasma
cell
differenti
stimul
solubl
cpg
cell
hi
int
characterist
phenotyp
describ
plasmablast
fig
fink
stimul
particul
particul
led
product
hi
hi
cell
characterist
plasma
cell
phenotyp
fig
line
plasma
cell
differenti
stage
observ
increas
igg
secret
stimul
solubl
cpg
particul
higher
level
igg
antibodi
bear
chain
cell
stimul
particul
respect
fig
b
compar
result
obtain
use
memori
b
cell
isol
fresh
cryopreserv
pbmc
fig
celltrac
violetlabel
cell
either
stimul
stimul
solubl
cpg
particul
cpg
particul
flow
cytometri
use
measur
prolifer
celltrac
violet
dilut
memori
b
cell
bear
bcr
contain
either
chain
number
box
indic
percentag
prolifer
cell
one
repres
result
three
independ
experi
shown
b
memori
b
cell
cultur
presenc
differ
stimulatori
condit
stimul
concentr
igg
antibodi
secret
cultur
supernat
presenc
antibodi
determin
eli
sa
left
mean
sd
igg
concentr
eight
differ
donor
middl
right
eli
sa
measur
ig
respect
result
repres
mean
od
valu
sd
two
replic
one
repres
result
eight
independ
experi
shown
gener
plasmablast
plasma
cell
differ
cultur
confirm
quantifi
transmiss
electron
microscopi
tem
unlik
plasmablast
plasma
cell
exhibit
expand
er
featur
typic
associ
largescal
antibodi
product
found
major
hi
int
cell
show
typic
plasmablast
morpholog
chang
er
contrast
hi
hi
cell
possess
expand
er
indic
hi
hi
cell
inde
plasma
cell
fig
c
character
hi
int
popul
gener
solubl
cpg
stimul
hi
hi
popul
obtain
stimul
analyz
express
specif
cell
surfac
marker
popul
flow
cytometri
hi
hi
popul
display
plasma
cell
phenotyp
character
higher
level
compar
hi
int
popul
fig
consist
plasma
cell
differenti
also
observ
lower
express
igd
hladr
fig
regard
cell
surfac
express
home
receptor
hi
hi
cell
character
increas
mucos
epiderm
chemokin
receptor
lselectin
fig
reduct
chemokin
receptor
compar
hi
int
popul
fig
examin
gene
express
profil
hi
hi
versu
hi
int
cell
popul
quantit
realtim
pcr
expect
two
cell
popul
substanti
downregul
key
transcript
factor
requir
naiv
b
cell
mainten
similarli
compar
hi
int
popul
hi
hi
cell
express
higher
level
transcript
factor
tf
gene
requir
plasma
cell
differenti
fig
b
also
analyz
earli
molecular
signal
pathway
trigger
activ
memori
b
cell
differ
stimuli
particul
particul
solubl
cpg
evalu
activ
statu
rang
intracellular
mediat
pakt
perk
respons
stimuli
observ
agreement
previous
publish
studi
eckldorna
batista
compar
memori
b
cell
stimul
solubl
cpg
particul
particul
stimul
result
sustain
phosphoryl
fig
c
howev
stimul
particul
induc
synergist
effect
phosphoryl
akt
erk
fig
c
support
find
flow
cytometri
tem
molecular
signal
character
stimul
preferenti
lead
gener
plasma
cell
perform
rnaseq
analysi
memori
b
cell
day
facssort
b
cell
stimul
cpg
day
five
donor
analysi
transcript
activ
variabl
constant
region
gene
reveal
stimul
result
specif
enhanc
express
gene
hi
hi
cell
minim
bystand
activ
b
cell
fig
e
furthermor
differenti
express
across
entir
transcriptom
confirm
upregul
gene
involv
antibodi
product
plasma
cell
marker
b
cell
stimul
comparison
memori
b
cell
cpgstimul
b
cell
plasmablast
respect
fig
f
collect
experiment
result
suggest
target
particul
cpg
via
bcr
work
select
method
stimul
human
memori
b
cell
prolifer
differenti
hi
hi
plasma
cell
lead
antibodi
product
demonstr
potenti
particul
trigger
plasma
cell
differenti
antibodi
secret
hypothes
could
extend
find
use
protocol
specif
activ
b
cell
infecti
antigen
vitro
accordingli
first
chose
tt
antigen
percentag
ttspecif
memori
cell
circul
blood
immun
individu
estim
gieseck
et
al
three
order
magnitud
lower
b
cell
bear
bcr
experi
memori
b
cell
either
unstimul
stimul
solubl
cpg
particul
ttcpg
import
note
memori
b
cell
purifi
healthi
donor
recent
vaccin
tetanu
otherwis
restimul
plasma
cell
differenti
assess
flow
cytometri
describ
earlier
interestingli
distinct
popul
hi
hi
plasma
cell
observ
stimul
ttcpg
fig
top
row
orang
quadrant
plasma
cell
popul
like
result
bcrspecif
recognit
particul
ttcpg
complet
absent
nonstimul
control
b
cell
donor
stimul
solubl
cpg
alon
fig
top
row
orang
quadrant
establish
hi
hi
popul
inde
contain
ttspecif
antibodysecret
cell
get
estim
frequenc
sort
popul
fac
perform
ttspecif
enzymelink
immunospot
eli
spot
assay
shown
fig
lower
row
plasma
cell
sort
memori
b
cell
stimul
particul
ttcpg
tt
specif
contrast
decreas
number
plasma
cell
n
present
memori
b
cell
stimul
solubl
cpg
test
specif
antibodi
produc
bulksort
plasma
cell
particul
ttcpg
stimul
perform
eli
sa
use
tt
coat
antigen
fig
right
found
antibodi
produc
particul
ttcpg
stimul
tt
specif
signal
produc
absenc
stimulu
moreov
eli
sa
result
show
antibodi
tt
specif
exhibit
crossreact
irrelev
protein
control
fig
right
unambigu
establish
number
ttspecif
plasma
cell
present
cultur
perform
singlecel
sort
hi
hi
plasma
cell
fac
cell
amplifi
correspond
heavi
light
chain
nest
pcr
clone
express
vector
produc
recombin
monoclon
human
antibodi
specif
vitro
transient
express
antibodi
cell
cultur
supernat
harvest
quantifi
express
igg
level
screen
antibodi
specif
eli
sa
fig
left
level
antibodi
product
individu
transfect
rang
mean
concentr
furthermor
halfmaxim
bind
ec
ttspecif
antibodi
also
determin
found
micromolar
rang
reinforc
tt
specif
antibodi
fig
b
right
eli
sa
result
sequenc
analysi
vh
segment
reveal
ttspecif
igg
express
antibodi
uniqu
sequenc
repres
two
three
time
fig
c
tabl
notabl
repres
enrich
compar
expect
circul
ttspecif
memori
b
cell
mention
previous
vitro
stimul
gieseck
et
al
moreov
multipl
encount
antibodi
sequenc
indic
vitro
prolifer
singl
b
cell
stimul
antibodi
also
show
extens
divers
v
j
gene
usag
domin
prefer
particular
gene
broad
distribut
heavi
chain
complementaritydetermin
region
length
tabl
recov
vh
segment
also
show
sequenc
similar
antitt
vh
gene
sequenc
previous
isol
vaccin
individu
de
kruif
et
al
dekoski
et
al
unpublish
data
interestingli
also
found
two
antibodi
ident
vh
jh
gene
usag
junction
carri
singl
point
mutat
tabl
fig
antibodi
although
share
ident
heavi
light
chain
gene
usag
differ
number
mutat
sequenc
indic
clonal
relat
tabl
fig
consist
antibodi
produc
individu
b
cell
like
origin
vivo
via
somat
hypermut
subsequ
prolifer
vitro
identif
uniqu
b
cell
clone
strongli
suggest
vitro
booster
vaccin
abl
sampl
wide
repertoir
ttspecif
b
cell
particular
take
consider
singl
activ
b
cell
use
singlecel
sequenc
analysi
assess
possibl
contribut
somat
hypermut
rearrang
vh
gene
segment
sequenc
region
compar
respect
germlin
ighv
gene
analysi
suggest
presenc
mutat
within
framework
region
fwr
fig
b
vh
gene
segment
show
higher
number
mutat
ttspecif
antibodi
compar
sequenc
unknown
specif
p
number
mutat
rang
ttspecif
antibodi
unknown
specif
fig
analysi
replac
r
silent
mutat
ttspecif
antibodi
show
replac
silent
mutat
cdr
frw
although
cdr
display
higher
overal
rs
ratio
fig
b
collect
higher
number
mutat
seen
gene
encod
ttspecif
antibodi
compar
encod
nonttspecif
clone
antibodi
higher
frequenc
replac
mutat
compar
silent
mutat
especi
cdr
suggest
antigendriven
select
anoth
possibl
howev
particul
ttcpg
may
preferenti
induc
differenti
prolifer
proport
ttspecif
memori
cell
higher
affin
mutat
furthermor
measur
affin
recombin
ttspecif
antibodi
biosensor
bind
analysi
fig
e
f
tabl
equilibrium
dissoci
constant
k
valu
obtain
reveal
picomolar
nanomolar
affin
fig
e
median
k
nm
fig
f
indic
highspecif
bind
antigen
thu
despit
low
number
ttspecif
memori
b
cell
circul
healthi
individu
abl
specif
prolifer
cell
one
repres
result
six
independ
experi
shown
b
concentr
igg
antibodi
secret
cultur
supernat
presenc
antibodi
determin
eli
sa
left
mean
sd
igg
concentr
three
differ
donor
middl
right
result
eli
sa
assay
detect
respect
result
repres
mean
od
valu
sd
two
replic
one
repres
result
three
independ
experi
shown
c
repres
tem
imag
hi
int
plasmablast
hi
hi
plasma
cell
six
independ
experi
bar
percentag
cell
expand
nonexpand
er
shown
chart
right
n
comparison
surfac
phenotyp
hi
int
blue
hi
hi
orang
cell
popul
particul
stimul
control
phenotyp
memori
b
cell
stimul
also
shown
flow
cytometri
data
one
repres
experi
four
independ
experi
shown
plot
gray
trace
repres
correspond
isotyp
control
number
panel
indic
percentag
cell
posit
indic
marker
e
specif
activ
memori
b
cell
lead
acquisit
plasma
cell
phenotyp
reveal
rnaseq
analysi
perform
mrna
isol
memori
b
cell
unstimul
stimul
cpg
transcript
profil
b
cell
popul
score
variabl
constant
region
gene
box
whisker
repres
upper
lower
quartil
score
inner
quartil
rang
respect
f
signific
plot
fold
chang
differenti
express
gene
determin
analysi
b
cell
stimul
unstimul
b
cell
b
cell
stimul
cpg
experi
data
deriv
pbmc
obtain
six
independ
donor
figur
gener
human
ttspecif
antibodi
sort
plasma
cell
repres
fac
profil
gate
strategi
sort
plasma
cell
orang
box
stimul
stimul
solubl
cpg
particul
ttcpg
enrich
ttspecif
plasma
cell
sort
determin
eli
spot
eli
sa
one
repres
eli
spot
three
show
iggproduc
plasma
cell
reactiv
tt
number
eli
spot
panel
repres
spot
count
well
cultur
supernat
sort
plasma
cell
test
eli
sa
right
presenc
induc
plasma
cell
activ
differenti
vitro
allow
recoveri
sever
antibodi
high
affin
antigen
establish
efficaci
vitro
stimul
system
use
protein
compon
standard
vaccin
program
infanc
childhood
want
determin
whether
could
use
gener
antibodi
influenza
viru
complex
natur
pathogen
common
influenza
viru
subtyp
infect
human
like
encount
mani
adult
determin
whether
could
activ
b
cell
individu
recent
infect
vaccin
influenza
stimul
memori
b
cell
two
healthi
donor
particul
ha
cpg
solubl
cpg
bsacpg
control
similar
observ
use
particul
ttcpg
defin
hi
hi
plasma
cell
popul
detect
memori
b
cell
stimul
particul
fig
upper
row
orang
quadrant
hi
hi
popul
contain
higher
frequenc
n
cell
secret
antibodi
compar
unstimul
n
solubl
cpgstimul
n
memori
b
cell
shown
result
eli
spot
assay
fig
lower
row
perform
singlecel
sort
hi
hi
plasma
cell
obtain
particul
challeng
next
pcr
amplifi
clone
express
recombin
antibodi
gene
individu
plasma
cell
two
donor
cell
eli
sa
assay
show
antibodi
specif
fig
b
indic
high
level
enrich
vitro
stimul
vh
sequenc
align
reveal
antibodi
uniqu
sequenc
two
donor
fig
c
analysi
also
reveal
two
clone
although
ident
gene
usag
vh
vl
region
exhibit
differ
number
point
mutat
vh
region
fig
interestingli
antibodi
show
strong
converg
restrict
select
ab
recent
isol
broadli
neutral
antibodi
capabl
neutral
influenza
subtyp
addit
found
true
antibodi
isol
studi
ab
capabl
neutral
joyc
et
al
analysi
somat
hypermut
rearrang
vh
gene
segment
antibodi
obtain
show
gene
encod
antibodi
contain
mutat
gene
encod
antibodi
fig
mutat
mostli
concentr
cdr
display
higher
rs
ratio
compar
region
indic
posit
antigendriven
select
fig
b
addit
determin
affin
antigenspecif
monoclon
antibodi
measur
k
via
surfac
plasmon
reson
result
k
valu
nanoto
picomolar
rang
median
nm
fig
e
tabl
indic
highspecif
bind
antigen
antibodi
crossreact
among
variou
influenza
viru
strain
detect
sever
studi
infect
immun
influenza
vaccin
corti
et
al
ekiert
et
al
check
reactiv
influenza
subtyp
screen
antibodi
ha
repres
influenza
subtyp
two
phylogenet
distinct
group
hemagglutinin
hemagglutinin
group
hemagglutinin
hemagglutinin
group
major
antibodi
react
exclus
antigen
howev
antibodi
show
crossreact
least
one
subtyp
fig
f
next
want
address
whether
could
also
gener
antigenspecif
antibodi
use
rare
influenza
subtyp
would
also
cross
react
panel
differ
influenza
subtyp
end
stimul
memori
b
cell
healthi
donor
uncommon
influenza
ha
stimul
particul
bsacpg
control
sort
singl
hi
hi
plasma
cell
clone
express
gene
encod
recombin
antibodi
seven
specif
fig
sequenc
align
analysi
antibodi
specif
tt
unrel
protein
control
data
repres
mean
od
valu
sd
two
replic
data
one
repres
experi
three
independ
repeat
shown
b
specif
recombin
antibodi
gener
singlesort
plasma
cell
test
eli
sa
cognat
igh
igl
gene
pair
transient
transfect
cell
cultur
supernat
test
presenc
antibodi
specif
tt
unrel
protein
control
left
mean
igg
antibodi
concentr
cutoff
valu
posit
signal
set
twofold
background
ec
valu
transfect
ttspecif
antibodi
extract
fit
raw
data
sigmoid
multiparamet
curv
right
c
pie
chart
outlin
frequenc
ttspecif
clone
percentag
ttposit
antibodi
denot
center
pie
chart
number
outsid
pie
chart
indic
number
antibodi
allel
sequenc
ident
igh
igl
chain
rearrang
comparison
absolut
number
somat
mutat
vh
gene
encod
ttspecif
nonttspecif
antibodi
box
repres
percentil
rang
horizont
bar
indic
median
whisker
extend
highest
lowest
data
point
twotail
p
valu
calcul
unpair
test
p
e
repres
octet
measur
kinet
ttspecif
antibodi
left
k
right
k
concentr
antibodi
repres
serial
twofold
dilut
f
k
ttspecif
antibodi
box
repres
percentil
rang
horizont
bar
indic
median
kd
valu
nm
six
ttspecif
antibodi
whisker
extend
highest
lowest
data
point
express
allel
reveal
six
differ
antibodi
gene
sequenc
fig
b
tabl
analysi
somat
hypermut
reveal
allel
encod
antibodi
contain
mutat
encod
antibodi
fig
c
indic
vivo
antigendriven
select
similar
observ
antibodi
allel
display
higher
rs
ratio
cdr
frw
region
fig
eli
sa
assay
antibodi
influenza
subtyp
reveal
high
degre
crossreact
ha
protein
fig
c
inde
panreact
across
subtyp
test
crossreact
remain
four
crossreact
group
strain
fig
c
similarli
use
antigen
stimul
b
cell
four
differ
donor
singlecel
sort
plasma
cell
sequenc
vh
vl
region
analysi
reveal
differ
antibodi
prove
posit
fig
e
tabl
analysi
somat
hypermut
show
gene
encod
antibodi
somat
mutat
unknown
specif
number
mutat
rang
cell
mutat
specif
fig
e
overal
found
compar
frw
cdr
possess
higher
frequenc
r
mutat
lower
frequenc
mutat
suggest
antigendriven
select
fig
f
interestingli
examin
crossreact
antibodi
previou
panel
influenza
ha
subtyp
found
antibodi
bound
least
one
influenza
subtyp
three
panreact
subtyp
fig
f
conclus
stimul
memori
b
cell
vitro
particul
abl
gener
high
frequenc
crossreact
even
panreact
antibodi
given
observ
antibodi
highli
crossreact
want
determin
whether
antibodi
gener
differ
ha
protein
capac
neutral
influenza
viru
end
chose
nine
mab
ec
valu
micromolar
rang
base
crossreact
differ
influenza
strain
test
abil
inhibit
either
plaqu
reduct
assay
fig
assay
reveal
two
antibodi
show
differ
degre
inhibit
fig
b
ic
antibodi
obtain
stimul
confid
interv
confid
interv
respect
wherea
none
seven
antibodi
show
signific
neutral
capac
fig
b
result
suggest
stimul
strategi
lead
antibodi
highli
crossreact
importantli
also
capac
neutral
viru
character
antibodi
investig
site
bind
ha
end
perform
competit
eli
sa
crossneutr
antiha
stem
antibodi
okuno
et
al
shown
fig
c
neutral
effici
compet
bind
ha
indic
antibodi
bind
ha
stem
substanti
find
evalu
bind
antibodi
differ
ha
mutant
eli
sa
took
advantag
wildtyp
ha
anew
wt
mutant
ha
contain
arginin
substitut
block
access
stem
epitop
delta
stem
mutant
nglycan
insert
also
prevent
access
stem
epitop
delta
stem
assay
ha
stembind
antibodi
ha
headbind
antibodi
use
control
although
antibodi
bound
posit
control
wt
bind
mutant
protein
compromis
hand
bind
ab
mutant
variant
unaffect
fig
lost
capac
bind
mutant
fig
confirm
antibodi
bind
stem
epitop
moreov
antibodi
also
show
reduc
bind
mutant
support
bind
ha
stem
region
fig
far
abl
use
vitro
vaccin
booster
stimul
b
cell
recogn
tt
although
unlik
experienc
healthi
donor
rare
b
cell
might
origin
result
previou
vaccin
infect
therefor
import
test
suitabl
approach
use
antigen
reli
preexist
memori
b
cell
previou
relatedviru
exposur
end
stimul
memori
b
cell
five
hivuninfect
individu
particul
singlecel
sort
sequenc
vh
vl
express
antibodi
eighteen
antibodi
shown
posit
recogn
recombin
test
eli
sa
flow
cytometri
fig
vh
gene
sequenc
align
reveal
antibodi
ident
sequenc
three
five
donor
suggest
vitro
b
cell
clonal
expans
fig
b
analysi
somat
hypermut
rearrang
vh
gene
segment
show
mutat
vh
sequenc
five
mutat
tabl
indic
b
cell
might
arisen
b
cell
previous
trigger
unknown
antigen
addit
also
identifi
five
antibodi
contain
zero
three
mutat
closest
germlin
tabl
may
reflect
b
cell
gave
rise
antibodi
affin
matur
import
establish
whether
antibodi
exhibit
certain
degre
specif
whether
simpli
polyreact
end
test
nine
repres
antibodi
panel
differ
protein
use
eli
sa
flow
cytometri
fig
c
b
although
seven
antibodi
abl
bind
one
protein
panel
antibodi
prove
neg
assay
fig
c
moreov
biolay
interferometri
bli
show
exhibit
measur
affin
nm
respect
suggest
specif
unlik
simpli
figur
gener
human
antibodi
singl
sort
plasma
cell
specif
recombin
antibodi
gener
sort
plasma
cell
one
donor
test
eli
sa
cognat
pair
igh
igl
gene
introduc
cell
transient
cotransfect
cultur
supernat
test
eli
sa
presenc
antibodi
specif
irrelev
protein
control
mean
igg
antibodi
concentr
cutoff
valu
posit
signal
taken
twofold
background
polyreact
fig
result
show
booster
vaccin
reli
exclus
activ
memori
b
cell
origin
relat
viral
infect
furthermor
methodolog
independ
cell
help
may
abl
overcom
toler
mechan
would
normal
prevent
polyreact
specif
c
competit
eli
sa
show
bind
inhibit
test
antibodi
mous
mab
ha
stem
dot
repres
mean
sd
two
replic
eli
sa
reactiv
indic
antibodi
wildtyp
ha
anew
wt
contain
arg
substitut
block
access
stem
epitop
delta
stem
nglycan
insert
also
prevent
access
stem
epitop
delta
stem
refer
antibodi
use
igg
human
stemdirect
bnab
igg
human
receptorbind
site
rb
direct
bnab
dot
repres
mean
sd
two
replic
respond
vaccin
overal
find
suggest
method
potenti
exploit
import
tool
studi
antigen
immunogen
vitro
introduc
vitro
booster
vaccin
strategi
allow
antigenspecif
human
b
cell
activ
differ
figur
gener
antibodi
singl
sort
plasma
cell
specif
recombin
antibodi
gener
stimul
memori
b
cell
five
hivuninfect
individu
analyz
eli
sa
cognat
pair
igh
igl
gene
introduc
cell
transient
cotransfect
cultur
supernat
test
presenc
igg
mean
igg
antibodi
concentr
cutoff
valu
posit
signal
taken
twofold
background
b
pie
chart
outlin
frequenc
clone
number
center
pie
chart
indic
percentag
antibodi
number
outsid
pie
chart
indic
number
antibodi
gene
sequenc
ident
igh
igl
chain
rearrang
c
reactiv
antibodi
panel
foreign
antigen
test
eli
sa
cutoff
valu
posit
taken
twofold
background
octet
measur
kinet
select
antibodi
recombin
wt
shown
arrow
repres
serial
dilut
antibodi
k
valu
highlight
insid
chart
entiat
method
exploit
exquisit
capac
bcr
discrimin
affin
result
b
cell
abl
bind
antigen
certain
avid
abl
intern
particulatecpg
synergist
bcr
tlr
activ
result
induct
robust
b
prolifer
differenti
plasma
cell
togeth
antibodi
secret
day
vitro
cultur
use
approach
abl
induc
specif
vitro
b
cell
respons
varieti
antigen
tt
influenza
mimick
vivo
vaccin
boost
allow
product
larg
panel
human
monoclon
antibodi
within
day
vitro
vaccin
boost
strategi
use
way
studi
antigenspecif
antibodi
repertoir
also
gener
human
mab
unlik
cell
effici
antigenspecif
b
cell
activ
vitro
difficult
achiev
bcr
engag
alon
insuffici
induc
robust
b
cell
activ
inde
b
cell
requir
second
signal
tlr
presenc
differ
interleukin
cocktail
includ
arpin
et
al
bernasconi
et
al
etting
et
al
huggin
et
al
type
stimul
use
extens
effect
activ
polyclon
b
cell
corti
et
al
smith
et
al
contrast
stimul
solubl
cpg
stimul
requir
high
concentr
forc
entri
nonspecif
uptak
cell
et
al
trigger
strong
activ
b
cell
irrespect
bcr
specif
contrast
advantag
method
bind
cpg
nanospher
prevent
nonspecif
entri
b
cell
particulatecpg
gain
access
compart
via
antigenspecif
bcr
intern
result
b
cell
bind
antigen
receiv
correct
signal
prolifer
differenti
importantli
particul
antibcr
stimul
alon
poor
induc
prolifer
differenti
similarli
solubl
cpg
alon
suffici
drive
prolifer
plasma
cell
differenti
stimul
bcr
tlr
howev
result
robust
prolifer
plasma
cell
differenti
antibodi
secret
futur
import
defin
precis
signal
involv
induct
plasma
cell
differenti
express
high
constitut
level
memori
b
cell
directli
trigger
cpg
induc
b
cell
prolifer
differenti
antibodysecret
cell
bernasconi
et
al
cpg
stimul
suggest
one
natur
mechan
maintain
serolog
memori
bernasconi
et
al
use
polyclon
activ
expand
ebvtransform
antigenspecif
b
cell
traggiai
et
al
earlier
studi
laboratori
provid
evid
platform
select
synerg
bcr
tlr
stimul
b
cell
use
particul
mice
crosslink
two
receptor
lead
specif
b
cell
prolifer
differenti
eckldorna
batista
furthermor
synerg
bcr
also
report
develop
human
autoimmun
diseas
leadbett
et
al
viglianti
et
al
optim
condit
vitro
stimul
first
valid
system
use
light
chain
model
target
antigen
show
integr
deliveri
two
signal
via
bcr
tlr
abl
drive
prolifer
differenti
memori
b
cell
plasma
cell
lead
increas
product
antibodi
addit
proof
principl
success
appli
approach
differ
antigen
demonstr
robust
reproduc
shown
vitro
stimul
memori
b
cell
particul
antigencpg
tt
influenza
ha
select
enrich
frequenc
hi
hi
antigenspecif
plasma
cell
despit
low
number
precursor
circul
peripher
blood
regardless
natur
pathogenderiv
antigen
chosen
coat
nanoparticl
plasma
cell
also
abl
secret
antibodi
specif
stimul
immunogen
analysi
variabl
region
sequenc
plasma
cell
recov
show
polyclon
respons
also
group
ident
variabl
region
repeat
isol
ident
v
j
sequenc
repres
strong
evid
prolifer
differenti
individu
b
cell
vitro
altern
could
reflect
vivo
clonal
size
also
found
vdj
sequenc
point
mutat
like
repres
sister
cell
underw
vivo
somat
mutat
individu
stimul
vitro
system
given
absenc
cell
help
short
time
cultur
unlik
system
induc
somat
hypermut
futur
modif
antigenspecif
vitro
b
cell
stimul
toward
induct
somat
mutat
affin
matur
repres
key
next
step
replic
full
immun
respons
cultur
agreement
previous
publish
data
corti
et
al
buricchi
et
al
goff
et
al
observ
degre
crossreact
antibodi
retriev
stimul
influenza
ha
subtyp
led
us
specul
may
possibl
exploit
methodolog
obtain
antibodi
antigen
previous
encount
vivo
suggest
function
assay
nine
antibodi
test
two
demonstr
neutral
activ
ha
inde
demonstr
two
neutral
antibodi
identifi
studi
specif
stalk
ha
shown
antibodi
stem
domain
ha
abl
neutral
wide
spectrum
influenza
viru
strain
subtyp
domain
compar
conserv
ekiert
et
al
corti
et
al
dreyfu
et
al
furthermor
three
antibodi
isol
stimul
clonal
relat
two
antibodi
recent
identifi
predominantli
neutral
antibodi
develop
upon
immun
human
joyc
et
al
futur
combin
methodolog
highthroughput
sequenc
may
prove
invalu
tool
studi
antigen
immunogen
vitro
far
sever
power
approach
use
isol
human
monoclon
antibodi
phage
display
ebv
immort
yeast
display
human
anim
model
mccafferti
et
al
clackson
et
al
arpin
et
al
tiller
et
al
boder
et
al
shultz
et
al
howev
methodolog
reli
largescal
screen
identifi
truli
antigenspecif
antibodi
although
recent
antigenspecif
b
cell
sort
singlecel
clone
circumv
issu
approach
still
restrict
highaffin
antibodyantigen
interact
franz
et
al
contrast
method
report
overcom
barrier
reli
singl
bcrantigen
interact
instead
avid
bcr
antigen
arrang
particl
approach
allow
antigenspecif
isol
ab
k
valu
rang
tt
influenza
ha
case
hiv
furthermor
method
induc
differenti
antigenspecif
plasma
cell
concomit
upregul
immunoglobulin
gene
compar
memori
cell
therebi
facilit
singlecel
antibodi
clone
thu
approach
could
appli
futur
fast
gener
human
monoclon
antibodi
offer
possibl
interrog
antigen
immunogen
vitro
achiev
matter
day
without
need
expens
gmp
protein
product
involv
patient
timeconsum
clinic
trial
joyc
et
al
approach
complement
exist
methodolog
also
offer
altern
vitro
phase
trial
help
futur
vaccin
develop
acceler
iter
immunogen
design
enter
phase
clinic
trial
summari
studi
provid
framework
novel
effici
vitro
platform
select
stimul
memori
b
cell
healthi
donor
lead
prolifer
differenti
plasma
cell
produc
antigenspecif
antibodi
even
antigenna
donor
methodolog
could
import
applic
product
therapeut
antibodi
specif
allow
product
within
shorter
time
frame
vitro
without
need
vaccin
bloodserum
donat
recent
infect
vaccin
individu
addit
method
offer
potenti
evalu
facilit
new
vaccin
develop
allow
effici
evalu
candid
target
antigen
new
wt
ha
delta
stem
mutant
human
monoclon
antibodi
provid
lingwood
provid
dr
burton
scripp
institut
san
diego
ca
human
cpg
odn
invivogen
peprotech
antibodi
use
follow
goat
antihuman
igg
specif
jackson
immunoresearch
laboratori
inc
antihuman
antihuman
antihuman
biotin
ebiosci
antihuman
antihuman
biotin
biolegend
antihuman
antihuman
igd
miltenyi
biotec
nanoparticl
coat
streptavidinco
nanoparticl
bang
laboratori
incub
biotinyl
cpg
biotinyl
protein
bsa
tt
overnight
coat
nanoparticl
block
pb
igg
free
h
rt
wash
twice
pb
bsa
igg
free
resuspend
cultur
medium
sonic
vac
hz
cole
parmer
optim
stimulatori
condit
determin
increas
amount
cpg
keep
amount
antibcrantigen
constant
coat
effici
measur
flow
cytometri
leukocyt
cone
obtain
south
east
region
blood
transfus
centr
uk
health
statu
donor
lack
prior
infect
base
mandatori
screen
blood
donat
describ
inform
contain
within
issuer
guidelin
http
www
transfusionguidelin
org
red
book
chapter
microbiolog
test
donor
donat
gener
specif
laboratori
test
procedur
gener
requir
http
www
transfusionguidelin
org
dsg
wb
pbmc
flush
leukocyt
cone
use
syring
isol
use
densiti
gradient
centrifug
lymphoprep
nycom
mean
pbmc
recov
per
cone
human
b
cell
purifi
use
memori
b
cell
isol
kit
miltenyi
biotec
stain
nm
celltrac
violet
thermo
fisher
scientif
accord
manufactur
protocol
stain
purifi
human
b
cell
particul
coat
biotinyl
cpg
biotinyl
antibcr
antibodi
antigen
ratio
nanoparticlescel
cultur
plate
purifi
memori
b
cell
well
co
complet
medium
rpmi
gibco
supplement
mem
nonessenti
amino
acid
sigmaaldrich
hepe
glutamax
u
ml
penicillinstreptomycin
mercaptoethanol
heatinactiv
fb
thermo
fisher
scientif
ng
ml
plate
ngml
ad
cell
cultur
anoth
total
stimul
b
cell
harvest
assess
prolifer
differenti
flow
cytometri
supernat
collect
day
cultur
antibcr
stimul
cell
subsequ
eli
sa
flow
cytometri
singlecel
sort
cell
harvest
stimul
block
fcr
block
reagent
miltenyi
biotec
wash
fac
buffer
pb
fb
bsa
cell
stain
antihuman
antihuman
wash
analyz
bd
fac
saria
iii
flow
cytometri
data
analyz
use
flowjo
version
tree
star
altern
plasma
cell
sort
fac
saria
iii
individu
well
pcr
plate
plate
seal
foil
film
biorad
immedi
frozen
dri
ice
storag
eli
sa
plate
corn
coat
antihuman
igg
follow
protein
tt
bsa
refer
protein
control
streptavidin
wt
incub
overnight
plate
wash
pb
tween
pbst
sigmaaldrich
block
proteinfre
buffer
thermo
fisher
scientif
h
rt
block
plate
sampl
ad
incub
rt
h
rins
pbst
plate
incub
antihuman
iggbiotin
antihuman
concentr
h
follow
extravidin
alkalin
phosphatas
sigmaaldrich
rt
h
plate
develop
ad
phosphatas
substrat
sigmafa
pnitrophenyl
phosphat
substrat
sigmaaldrich
od
determin
nm
spectramax
micropl
reader
molecular
devic
competit
eli
sa
twofold
serial
dilut
test
antibodi
premix
refer
mous
antihuman
stem
antibodi
takara
bio
inc
noncoat
ubottom
plate
costar
premix
antibodi
transfer
coat
plate
incub
h
rt
wash
ad
ml
antimous
secondari
antibodi
coupl
biotin
goat
antimous
igg
biotin
human
adsorb
southern
biotech
eli
sa
continu
previous
describ
transmiss
electron
microscopi
b
cell
popul
sort
volvol
formaldehyd
phosphat
buffer
final
concentr
centrifug
gentli
g
min
resuspend
volvol
volvol
formaldehyd
phosphat
buffer
min
rt
cell
postfix
osmium
potassium
ferricyanid
h
stain
thiocarbohydrazid
min
follow
aqueou
osmium
min
aqueou
uranyl
acet
overnight
pellet
stain
walton
lead
aspart
min
dehydr
stepwis
ethanol
seri
min
ice
min
rt
embed
durcupan
acm
sigmaaldrich
block
section
use
ultramicrotom
leica
microsystem
pick
hexagon
copper
grid
gilder
grid
section
view
use
tecnai
spirit
transmiss
electron
microscop
fei
compani
imag
captur
use
oriu
ccd
gatan
cell
within
sever
randomli
select
grid
area
imag
cell
per
condit
use
four
donor
quantifi
base
structur
er
expand
nonexpand
eli
spot
eli
spot
plate
emd
millipor
coat
ml
tt
overnight
incub
plate
wash
three
time
steril
pb
block
rpmi
fb
rt
plate
wash
stimul
b
cell
ad
plate
complet
medium
incub
co
least
h
plate
wash
pbst
sigmaaldrich
goat
antihuman
iggbiotin
ad
well
h
plate
wash
pbst
incub
extravidin
alkalin
phosphatas
sigmaaldrich
develop
ad
sigmafast
bcipnbt
sigmaaldrich
substrat
reaction
stop
wash
distil
water
plate
airdri
spot
imag
count
eli
spot
reader
ctlimmunospot
firststrand
cdna
singl
cell
synthes
origin
plate
superscript
iii
revers
transcript
invitrogen
use
oligodt
nest
pcr
reaction
express
vector
clone
perform
previous
describ
tiller
et
al
brief
cdna
synthes
use
ng
random
hexam
primer
pd
n
ge
healthcar
mm
nucleotid
dntpmix
invitrogen
dithiothreitol
invitrogen
vol
vol
igep
sigmaaldrich
u
rnasin
promega
u
prime
rnase
inhibitor
eppendorf
u
superscript
iii
revers
transcript
invitrogen
follow
temperatur
min
min
min
min
igh
v
gene
transcript
amplifi
independ
nest
pcr
start
cdna
templat
round
pcr
perform
cycl
first
pcr
second
pcr
igh
pcr
product
purifi
use
qiaquick
pcr
purif
kit
qia
gen
digest
respect
restrict
enzym
agei
sali
xhoi
new
england
biolab
inc
digest
pcr
product
purifi
ligat
human
express
vector
compet
escherichia
coli
bacteria
clontech
transform
ligat
product
coloni
screen
pcr
use
ab
sens
forward
primer
igg
intern
revers
primer
plasmid
dna
isol
bacteria
cultur
grown
h
terrif
broth
difco
laboratori
contain
ampicillin
sigmaaldrich
use
qiaprep
spin
column
qia
gen
kit
reagent
use
accord
manufactur
instruct
antibodi
sequenc
analysi
dna
sequenc
perform
appli
biosystem
dna
analyz
sequenc
compar
known
germlin
gene
assign
ighv
ighj
germlin
sequenc
base
highest
percentag
sequenc
homolog
use
imgt
http
www
imgt
org
igbla
st
http
www
ncbi
nlm
nih
gov
igblast
databas
variabl
heavi
light
chain
antibodi
gene
analyz
gene
usag
mutat
within
length
replac
silent
mutat
determin
normal
respect
length
region
defin
imgt
igbla
st
heavi
light
chain
plasmid
cotransfect
exponenti
grow
cell
atcc
electropor
amaxa
nucleofector
lonza
accord
manufactur
protocol
supernat
harvest
analyz
eli
sa
recombin
antibodi
product
antibodi
name
codifi
antigen
stimulu
follow
antibodi
number
exampl
recombin
antibodi
concentr
determin
eli
sa
previous
describ
tiller
et
al
neutral
assay
recombin
antibodi
purifi
supernat
transfect
cell
cultur
serumfre
optimem
medium
thermo
fisher
scientif
cell
debri
remov
centrifug
rpm
min
human
igg
purifi
akta
start
use
protein
column
hitrap
mabselect
sure
ge
healthcar
accord
manufactur
instruct
kinet
interact
mab
recombin
ha
protein
determin
surfac
plasmon
reson
spr
use
biacor
system
biolay
interferometri
use
fortebio
octet
biacor
purifi
ha
protein
dilut
mm
sodium
acet
ph
coval
immobil
amin
coupl
dextran
matrix
sensor
chip
biacor
target
densiti
respons
unit
unreact
activ
ester
group
block
ethanolamin
five
purifi
influenzaspecif
mab
concentr
rang
nm
buffer
biacor
inject
immobil
ha
protein
refer
cell
surfac
associ
rate
k
dissoci
rate
k
equilibrium
dissoci
constant
k
calcul
align
bind
curv
global
fit
langmuir
bind
model
use
biaevalu
octect
perform
black
plate
nunc
microwel
plate
thermo
fisher
scientif
total
work
volum
sampl
buffer
per
well
assay
streptavidin
biosensor
tip
fortebio
octect
prewet
kinet
buffer
least
min
afterward
streptavidin
biosensor
tip
load
biotinyl
antigen
pb
follow
addit
equilibr
step
subsequ
associ
biotinyl
antigen
antibodi
concentr
rang
nm
kinet
buffer
conduct
associ
concentr
perform
final
dissoci
monitor
kinet
buffer
result
plot
show
dissoci
influenza
plaqu
assay
perform
use
adapt
previous
describ
plaqu
assay
method
matrosovich
et
al
seri
six
twofold
dilut
antibodi
polyclon
antiserum
posit
control
specif
viru
prepar
use
dmem
contain
uspnfp
trypsin
ntosyllphenylalanyl
chloromethyl
keton
tpck
dilut
incub
volvol
ratio
pfuml
either
co
h
sampl
regularli
invert
ensur
homogen
sixwel
plate
mdck
cell
seed
cellsml
day
assay
wash
twice
pb
virusmab
mix
overlaid
onto
individu
well
one
well
per
dilut
incub
cell
overlaid
ml
avicel
solut
avicel
dmem
contain
uspnfp
trypsin
tpck
sodium
bicarbon
incub
co
plate
wash
twice
use
pb
subsequ
fix
stain
use
formalin
crystal
violet
solut
formalin
crystal
violet
ethanol
h
mab
test
triplic
back
titrat
plaqu
assay
also
perform
viru
confirm
viru
titer
within
accept
paramet
titer
determin
backtitr
subsequ
use
determin
ic
calcul
plaqu
visual
count
ic
data
calcul
use
prism
graphpad
softwar
stimul
hi
int
hi
hi
cell
sort
lyse
rna
extract
use
magmax
total
rna
isol
kit
thermo
fisher
scientif
revers
transcrib
use
random
hexam
transcriptor
firststrand
cdna
kit
roch
quantit
realtim
pcr
perform
use
viia
system
cdna
level
detect
use
power
sybr
green
thermo
fisher
scientif
normal
gap
dh
sampl
report
valu
normal
memori
b
cell
oligonucleotid
use
qpcr
follow
forward
ggt
ctg
gtt
agt
cca
revers
cac
act
tgt
agg
gtt
forward
caa
ctt
tgg
cct
ctt
revers
tt
c
atg
tgg
ctt
ttc
forward
gga
gtg
aat
cag
ctt
revers
ttg
atg
ctt
cct
gtc
forward
gaa
gct
gga
ggg
act
revers
ggg
cac
aag
cat
aaa
forward
ccc
ctc
cag
aac
atc
revers
ggg
agg
ctg
gta
agg
differ
gene
express
hi
int
hi
hi
calcul
test
statist
signific
determin
use
holmsidak
method
correct
multipl
comparison
p
purifi
memori
b
cell
equilibr
complet
medium
min
prewarm
particul
coat
biotinyl
cpg
biotinyl
anti
bcr
biotinyl
antibcr
ad
ratio
particul
per
b
cell
solubl
cpg
ad
final
concentr
indic
time
cell
lyse
buffer
analyz
sdspage
follow
immunoblot
indic
antibodi
antiphospholyn
antiphosphoerk
antiphosphoakt
antiphosphosyk
antierk
cell
signal
technolog
densiti
band
quantifi
densitometri
correct
background
normal
densiti
actin
band
sampl
made
rel
unstimul
zero
time
point
condit
statist
differ
length
v
gene
mutat
calcul
pair
twotail
student
test
differ
consid
statist
signific
valu
p
ec
valu
calcul
use
nonlinear
regress
curv
fit
paramet
log
agonist
vs
normal
respons
variabl
slope
ic
logic
valu
calcul
use
nonlinear
regress
curv
fit
paramet
log
inhibitor
vs
normal
respons
variabl
slope
statist
analys
perform
prism
h
onlin
supplement
materi
fig
provid
comparison
vitro
stimul
memori
b
cell
obtain
fresh
versu
frozen
pbmc
fig
describ
phenotyp
high
int
high
high
cell
popul
gene
express
transcript
factor
involv
plasma
cell
differenti
fig
show
analysi
sequenc
ttspecif
antibodi
fig
show
sequenc
analysi
haspecif
antibodi
fig
show
analysi
reactiv
bind
antibodi
flow
cytometri
tabl
list
uniqu
antigenspecif
antibodi
sequenc
isol
singl
plasma
cell
obtain
stimul
memori
cell
healthi
individu
particul
ttcpg
tabl
show
biolay
interferometri
determin
k
k
k
select
ttspecif
antibodi
bind
immobil
antigen
tabl
show
uniqu
antigenspecif
antibodi
sequenc
isol
singl
plasma
cell
obtain
stimul
particul
tabl
show
spr
measur
k
k
k
select
antibodi
bind
immobil
antigen
tabl
show
characterist
uniqu
antigenspecif
antibodi
sequenc
isol
singl
plasma
cell
obtain
stimul
particul
tabl
show
characterist
uniqu
antigenspecif
antibodi
sequenc
isol
singl
plasma
cell
obtain
stimul
particul
tabl
show
characterist
uniqu
antigenspecif
antibodi
sequenc
isol
singl
plasma
cell
obtain
stimul
particul
tabl
includ
excel
file
show
sequenc
antibodi
isol
studi
